You have 9 free searches left this month | for more free features.

Condition

Small Cell Lung Cancer (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Merck Sharp & Dohme LLC (1)

Collaborator

Intervention

carboplatin (1)

cisplatin (1)

etoposide (1)

lenvatinib (1)

mk-4830 (1)

mk-5890 (1)

pembrolizumab (1)

Study Documents

Intervention Type

biological (1)

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

mk-5890

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Small Cell Lung Cancer Trial in Worldwide (Pembrolizumab, MK-4830, MK-5890)

Recruiting

Small Cell Lung Cancer

Pembrolizumab
+6 more

Gilbert, Arizona
+48 more

Jan 19, 2023